[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"eyelid-wound\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:eyelid-wound":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":5},"100610954","evaluation-of-patient-satisfaction-with-blephaderm-as-a-complementary-care-in-post-eyelid-surgery-100610954",false,"NCT07234292","Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery","Evaluation of Patient Satisfaction With a New Preservative-free Eyelid Cream as a Complementary Care in Post-eyelid Surgery: The ADMIRE Study","Inclusion Criteria:\n\n* Age ≥ 18 years old\n* Patients planning a blepharoplasty or a ptosis surgery in at least one eye.\n* Patient affiliated to a health social security system\n* Female of childbearing potential should use a medically accepted contraceptive regimen since at least 12 weeks before the beginning of the study, during all the study and at least 1 month after the study end.\n\nExclusion Criteria:\n\nIn terms of population:\n\n* Pregnant or nursing woman or planning a pregnancy during the study.\n* Patient who had been deprived of their freedom by administrative or legal decision\n* Minor patient.\n* Major patient who is under guardianship or who is not able to express his non opposition.\n* Patient suspected to be non-compliant according to the investigator's judgment.\n* Patient enrolled in another clinical trial or which exclusion period is not over.\n\nIn terms of associated pathology\n\n* Patient with a history or active systemic condition or receiving a medication which, in the investigator's judgment, put the patient at undue risk.\n* Patient suffering from a severe or progressive disease.\n* Patient with known or suspected hypersensitivity to one of the components of the product.\n\nRelated to previous or ongoing treatment\n\n* Patient undergoing a topical treatment on the test area or a systemic treatment.\n* Patient under a long-term corticosteroid, NSAID or HIV therapy at the investigator appreciation.\n* Patient under immunosuppressive therapy\n* Patient under bisphosphonate therapy\n* Patient having Type 1 diabetes\n* Patient having atopic or eczema skin\n\nIn terms of lifestyle\n\n* Intensive exposure to sunlight or UV-rays foreseen during the study.\n* Patient planning to change her\u002Fhis life habits during the study.\n* Patient with an excessive consumption of alcohol and\u002For tobacco defined as:\n* an excessive consumption of alcohol: Drinking more than\n* 4 units a day for adult men and more than 2 units a day for adult women,\n* an excessive consumption of tobacco: ≥15-20 Cigarettes Per Day (CPD).","ALL","18 Years",{"count":19,"type":20},30,"ESTIMATED","OBSERVATIONAL","The goal of this non-interventional, open and monocentric study is to evaluate the satisfaction of 30 patients, after 3 months with Blephaderm eyelid cream, as a complementary care in post-eyelid surgery (Blepharopasty or ptosis).\n\nThe participant will be asked to use Blephaderm twice a day. The patient satisfaction will be evaluated using a VAS scale.",[24],"Eyelid; Wound","RECRUITING","2026-04-28",{"date":28,"type":29},"2026-05-04","ACTUAL",{"date":31,"type":29},"2025-10-30",{"date":33,"type":20},"2026-12-15",{"name":35,"class":36},"Laboratoires Thea","INDUSTRY"]